These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7030527)

  • 1. Studies on the responses of plasma renin activity and aldosterone and cortisol levels to dopaminergic and opiate stimuli in man.
    Lightman SL
    Clin Endocrinol (Oxf); 1981 Jul; 15(1):45-52. PubMed ID: 7030527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the renin-angiotensin-aldosterone system by L-dopa with and without inhibition of extracerebral dopa decarboxylase in man.
    Barbieri C; Caldara R; Ferrari C; Crossignani RM; Recchia M
    Clin Sci (Lond); 1981 Aug; 61(2):187-90. PubMed ID: 7021041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for dopaminergic control of aldosterone in man.
    Frisina N; Costa G; Buemi M
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):741-5. PubMed ID: 6360433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term infusions of dopa and carbidopa on renin and steroid secretion in the rat.
    Inglis GC; Kenyon CJ
    Endocrinology; 1992 Dec; 131(6):2941-5. PubMed ID: 1446631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The dopaminergic system and aldosterone secretion. II. Effect of L-dopa and dexamethasone on aldosterone biosynthesis].
    Frisina N; Buemi M; Lasco A; Vitulo F; Ciraolo O; Costa G; Nicita-Mauro V
    Boll Soc Ital Biol Sper; 1980 Nov; 56(22):2290-6. PubMed ID: 7013772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR; Beck FW
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.
    Sowers JR; Sharp B; McCallum RW
    J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The dopaminergic system and aldosterone secretion. I. Suppressive effects of L-dopa on secondary hyperaldosteronism].
    Frisina N; Buemi M; Ciraolo O; Naso G; Lasco A; Costa G
    Boll Soc Ital Biol Sper; 1980 Nov; 56(22):2284-8. PubMed ID: 7013771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the renin--aldosterone axis and of prolactin secretion during pregnancy by L-dopa.
    Kaulhausen H; Oney T; Leyendecker G
    Br J Obstet Gynaecol; 1982 Jun; 89(6):483-8. PubMed ID: 7044409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the role of dopamine receptors in aldosterone secretion.
    Frisina N; Buemi M; Macri' I
    Ann Endocrinol (Paris); 1984; 45(6):387-91. PubMed ID: 6100228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic control of aldosterone secretion is independent of the renin-angiotensin system in rats.
    Sowers JR; Tuck ML; Barrett J; Sambhi MP; Golub MS
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():101s-103s. PubMed ID: 7004716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs.
    Blair ML; Reid IA; Ganong WF
    J Pharmacol Exp Ther; 1977 Jul; 202(1):209-15. PubMed ID: 874815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA; Frohman LA
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of peripheral adrenoreceptors and vasopressin in the suppression of plasma renin activity by L-dopa in carbidopa-treated dogs.
    Blair ML; Reid IA; Keil LC; Ganong WF
    J Pharmacol Exp Ther; 1979 Sep; 210(3):368-72. PubMed ID: 480187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of levodopa alone and in combination with dopa-decarboxylase inhibitors on plasma renin activity in patients with Parkinson's disease.
    Rappelli A; Glorioso N; Tedde R; Dessi'-Fulgheri P; Monaco F
    J Neurol Neurosurg Psychiatry; 1978 Oct; 41(10):915-8. PubMed ID: 731241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey.
    Sowers JR; Eggena P; Phillips D
    Metabolism; 1982 Dec; 31(12):1219-23. PubMed ID: 7144566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure and vasopressin in progressive autonomic failure. Response to postural stimulation, L-dopa and naloxone.
    Puritz R; Lightman SL; Wilcox CS; Forsling M; Bannister R
    Brain; 1983 Jun; 106 (Pt 2)():503-11. PubMed ID: 6850280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine inhibits the aldosterone response to upright posture.
    Malchoff CD; Hughes J; Sen S; Jackson S; Carey RM
    J Clin Endocrinol Metab; 1986 Jul; 63(1):197-201. PubMed ID: 3519647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of central and peripheral dopamine antagonism on aldosterone secretion: evidence for adrenal mechanism.
    Stern N; Eggena P; Chandler W; Tuck ML
    Am J Physiol; 1989 Oct; 257(4 Pt 1):E588-94. PubMed ID: 2679132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of naloxone on the adrenal cortex in primary aldosteronism.
    Fallo F; Boscaro M; Sonino N; Mantero F
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):280-2. PubMed ID: 2839206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.